00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Novo Nordisk said a pill version of its weight loss drug Wegevy is now available in the U.S.,
00:07offering an oral treatment option for obesity, according to CBS News.
00:12The company said the daily pill starts at 1.5 milligrams and costs $149 per month for
00:18self-paying patients. A 4-milligram dose is available at the same price through April 15
00:23before rising to $199. The Food and Drug Administration approved the pill in December,
00:30Novo Nordisk said the pill contains 25 milligrams of semaglutide,
00:34the same ingredient used in injectable Wegevy and Ozempic,
00:37and has similar side effects such as nausea and diarrhea. The company said trial participants
00:42lost about 14% of body weight, with continued users losing about 17%.
00:48For all things money, visit Benzinga.com.
Comments